Indian pharmaceutical companies regularly leverage events like the Indian Pharmaceutical Congress (IPC) to showcase their latest advancements in drug development, technology integration, and adherence to global quality standards.
Industry leaders emphasize that IPC serves as a crucial platform for demonstrating India’s capabilities in innovation and its significant contributions to global healthcare through affordable medicines and high-quality generics.
Harish K Jain, president of FOPE and director of Embiotic Labs, underscored the profound impact of IPC on the pharmacy profession, stating that the event has played a pivotal role in fostering industry growth since India’s independence. He highlighted IPC as a vital forum for pharmacy professionals to exchange ideas, gain insights, and shape the future of the profession.
Manoj Palrecha, president of Karnataka Drugs and Pharmaceutical Manufacturers Association (KDPMA) and managing director of Lake Chemicals, emphasized IPC’s role in facilitating academia-industry partnerships. He noted that IPC provides an essential platform for pharmacy colleges to explore internship opportunities for their students and for industry leaders to assess the talent pool through student poster presentations.
Kaushik Desai, a pharmaceutical consultant, reflected on IPC’s enduring legacy as it enters its 73rd year, describing it as a hallmark event that draws over 7,000 professionals across various pharmacy sectors including industry, academia, hospital, clinical, community, and regulatory fields. Desai highlighted IPC’s multiple scientific tracks covering the latest research, innovations, and technological advances, alongside global faculty contributions and CEO meetings that drive industry growth strategies.
Archana Dubey, EVP of international sales at Bal Pharma, emphasized how events like IPC elevate the stature of Indian pharma globally, showcasing India’s strengths in R&D and quality that set it apart from global competitors.
Suresh Khanna, designated partner at Dossier Solutions LLP, highlighted IPC as a pivotal platform for fostering partnerships between Indian and global pharmaceutical companies, particularly emphasizing Hyderabad’s strategic importance in the pharmaceutical industry’s global landscape.
IPC continues to play a pivotal role in driving innovation, collaboration, and strategic partnerships within the Indian pharmaceutical sector, reinforcing its significance as a global leader in pharmaceutical advancements.